NCLT shareholder meeting for amalgamation scheme held on July 2, 2026

Nclt Scheme FiledStrategic Transactions View source PDF Explain this filing

DRAGARWQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹5035.00

prior close

₹5035.50

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-0.1% vs market

Hospital peers, median of 23sector+0.4%-0.9% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.7

10m

+2.5

15m

+1.3

30m

+1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5-0.3-0.1+0.4-0.9

Next day

-0.7-0.1-0.6+0.3-1.0

-0.7-0.8+0.1-0.4-0.3

-2.3-2.8+0.5-2.9+0.6

-0.3-1.0+0.7-0.6+0.3

-3.4+0.4-3.8-0.1-3.3

-0.2-0.5+0.3-1.6+1.4

15d

-0.3-1.9+1.6-2.0+1.7

+0.3+0.4-0.2-1.9+2.1

+6.4+3.5+2.9-1.2+7.6

+4.3+2.0+2.3-9.4+13.6

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr Agarwals Eye Hospital held an NCLT-convened shareholder meeting on July 2, 2026 to consider the Scheme of Amalgamation with Dr Agarwals Health Care Limited under Sections 230-232 of the Companies Act, 2013. Of 23,610 total shareholders on record date June 3, 2026, 556 attended (4 promoter group, 552 public). The special resolution was put to vote via remote e-voting, venue e-voting and polling papers. Scrutinizer Shri Sriram Ananth will submit consolidated voting report. Final results awaited.

Likely market impact

Amalgamation with Dr Agarwals Health Care advances to voting stage. Await consolidated shareholder approval result.